AstraZeneca doubles Lokelma output with $445m Texas plant expansion
AstraZeneca has unveiled a newly expanded manufacturing facility in Texas to the tune of $445m, as the drugmaker aims to…
News
Novo Nordisk snaps up Omeros’ rare disease asset for up to $2.1bn
Bavarian Nordic’s shareholders and board in standoff amid takeover offer
Tubulis closes $361m in Series C to advance cancer treatment
Oceanpine Capital to acquire 80% equity stake in Beijing Jacoray
Healthcare burden of neurological conditions “growing”, WHO warns
Kirkland & Ellis dominates M&A legal advisory in first three quarters of 2025
Goldman Sachs and Houlihan Lokey lead in M&A advisory for Q1-Q3 2025
